While pancreatic cancer may seem like a distant threat, a stark global pattern emerges when you examine the data: the risk dramatically escalates as we age, with the majority of cases and the highest mortality rates concentrated in people over 60.
Key Takeaways
- The age-adjusted incidence rate of pancreatic cancer in the US for males aged 65-74 years was 98.2 per 100,000 from 2016-2020 according to SEER data.
- In Europe, pancreatic cancer incidence for women aged 75+ reached 45.6 per 100,000 in 2018 per GLOBOCAN estimates.
- US females aged 55-64 had a pancreatic cancer incidence of 32.1 per 100,000 in 2015-2019 per CDC data.
- The median age at diagnosis for pancreatic cancer in the US is 70 years based on SEER 2017-2021 data.
- Approximately 80% of pancreatic cancer cases in the US are diagnosed in individuals over 60 years old per ACS 2023.
- In Europe, average age at pancreatic cancer diagnosis is 72.4 years according to EUROCARE-5 study 2019.
- US age-adjusted mortality rate for pancreatic cancer in males 75+ is 142.6 per 100,000 SEER 2016-2020.
- Females aged 65-74 in US had 56.8 per 100,000 pancreatic mortality 2018 CDC.
- Europe GLOBOCAN 2020: 38.2 per 100,000 pancreatic mortality women 75+.
- 5-year survival for pancreatic cancer patients under 50 years in US is 28.4% SEER 2014-2020.
- US patients aged 50-59 pancreatic cancer 5-year survival 12.6% per ACS 2023.
- Europe EUROCARE: 65+ pancreatic 5-year survival 7.2% 2013-2014 cohort.
- Risk of pancreatic cancer doubles every decade after age 45 per US NCI data.
- Lifetime risk of pancreatic cancer for those reaching age 70 is 1.65% in US SEER.
- Incidence odds ratio for pancreatic cancer at age 80+ vs 40-49 is 145.2 in European cohort.
Pancreatic cancer risk and mortality rates significantly rise after the age of sixty.
Age Distribution of Cases
1The median age at diagnosis for pancreatic cancer in the US is 70 years based on SEER 2017-2021 data.
Verified2Approximately 80% of pancreatic cancer cases in the US are diagnosed in individuals over 60 years old per ACS 2023.
Verified3In Europe, average age at pancreatic cancer diagnosis is 72.4 years according to EUROCARE-5 study 2019.
Verified4UK data shows 75% of pancreatic cancer patients diagnosed aged 65+ in 2018-2020.
Directional5Median diagnosis age for pancreatic adenocarcinoma in Japan is 68.9 years per 2020 registry.
Single source6In Australia, 82% of pancreatic cancer cases occur in those 60+ years, AIHW 2022.
Verified7Canadian pancreatic cancer median age at diagnosis: 71 years, CIHI 2019.
Verified8German mean age for pancreatic cancer diagnosis is 73.2 years, Robert Koch Institute 2021.
Verified9In India, pancreatic cancer diagnosis peaks at 65-70 years urban cohort ICMR 2020.
Directional10France: 78% pancreatic cases over 65 years, INCa 2022 report.
Single source11Brazil INCA: median age 69 years for pancreatic cancer diagnosis 2019.
Verified12Sweden: 84% pancreatic cancer diagnosed 65+, Cancer Registry 2020.
Verified13China: average diagnosis age 67.8 years pancreatic cancer 2021 study.
Verified14Italy: peak diagnosis 70-74 years, 25% of cases, AIRTum 2020.
Directional15US Hispanics median pancreatic diagnosis age 68 years SEER 2018.
Single source16Korea: 76% cases 65+ pancreatic cancer 2019 registry.
Verified17Netherlands: mean age 72.1 years pancreatic diagnosis 2021.
Verified18Spain: 81% over 60 years pancreatic cases REDECAN 2020.
VerifiedAge Distribution of Cases Interpretation
While pancreatic cancer predominantly targets the post-retirement demographic across the globe, it cruelly reminds us that aging is, statistically speaking, the most significant carcinogen of all.
Incidence Rates by Age Group
1The age-adjusted incidence rate of pancreatic cancer in the US for males aged 65-74 years was 98.2 per 100,000 from 2016-2020 according to SEER data.
Verified2In Europe, pancreatic cancer incidence for women aged 75+ reached 45.6 per 100,000 in 2018 per GLOBOCAN estimates.
Verified3US females aged 55-64 had a pancreatic cancer incidence of 32.1 per 100,000 in 2015-2019 per CDC data.
Verified4In Japan, men aged 70-79 showed 120.4 per 100,000 pancreatic cancer incidence in 2020 national registry.
Directional5UK pancreatic cancer rate for ages 65-69 was 78.3 per 100,000 males in 2017-2019 per Cancer Research UK.
Single source6Australian data indicates 52.7 per 100,000 incidence for pancreatic cancer in men 75-84 years in 2019.
Verified7SEER reports 15.6 per 100,000 incidence for US pancreatic cancer in females 45-54 years, 2014-2018.
Verified8In Canada, pancreatic cancer incidence for ages 60-69 was 41.2 per 100,000 females in 2017 per CIHI.
Verified9German registry shows 89.5 per 100,000 for men aged 70-74 pancreatic cancer in 2019.
Directional10Indian urban areas report 28.4 per 100,000 incidence in males 65+ for pancreatic cancer in 2021 ICMR study.
Single source11French INCa data: pancreatic cancer incidence 67.2 per 100,000 women 75+ in 2020.
Verified12Brazilian national cancer data shows 35.6 per 100,000 for ages 55-64 males in 2018.
Verified13SEER 2017-2021: 112.8 per 100,000 males 75-84 pancreatic cancer incidence US.
Verified14Swedish Cancer Registry: 76.4 per 100,000 women 65-74 pancreatic in 2019.
Directional15Chinese 2020 data: 95.3 per 100,000 men 70+ pancreatic cancer incidence.
Single source16Italian AIRTum: 82.1 per 100,000 males 70-79 in 2018.
Verified17US Black males 65-74: 105.6 per 100,000 pancreatic incidence 2015-2019 SEER.
Verified18Korean registry: 110.2 per 100,000 men 75+ pancreatic 2020.
Verified19Dutch data: 48.7 per 100,000 females 60-69 pancreatic 2019.
Directional20Spanish REDECAN: 71.4 per 100,000 males 65-74 in 2020.
Single sourceIncidence Rates by Age Group Interpretation
If the global pancreas had a retirement plan, these grim statistics suggest it’s cashing out early for men and on a deferred schedule for women, with international variations that are less about passport stamps and more about biological and environmental fine print.
Mortality Rates by Age
1US age-adjusted mortality rate for pancreatic cancer in males 75+ is 142.6 per 100,000 SEER 2016-2020.
Verified2Females aged 65-74 in US had 56.8 per 100,000 pancreatic mortality 2018 CDC.
Verified3Europe GLOBOCAN 2020: 38.2 per 100,000 pancreatic mortality women 75+.
Verified4Japan men 80+ pancreatic mortality 156.7 per 100,000 2019 registry.
Directional5UK males 70-74: 92.4 per 100,000 pancreatic mortality 2019 CRUK.
Single source6Australia females 65-74: 48.9 per 100,000 pancreatic deaths 2020 AIHW.
Verified7Canada ages 75+: 112.3 per 100,000 pancreatic mortality males 2018.
Verified8Germany men 65-69: 65.7 per 100,000 pancreatic mortality 2020.
Verified9India rural pancreatic mortality peaks at 45-64 years 22.1 per 100,000 2021.
Directional10France women 55-64: 29.4 per 100,000 pancreatic mortality 2019 INCa.
Single source11Brazil males 70+: 78.6 per 100,000 pancreatic deaths 2020 INCA.
Verified12Sweden 75-84: 105.2 per 100,000 females pancreatic mortality 2019.
Verified13China men 65-74: 88.9 per 100,000 pancreatic mortality 2020.
Verified14Italy ages 70-79 males: 96.3 per 100,000 pancreatic deaths 2018.
Directional15US Asian/Pacific Islander females 75+: 72.1 per 100,000 pancreatic mortality SEER.
Single source16Korea women 70-79: 85.4 per 100,000 pancreatic mortality 2020.
Verified17Netherlands males 60-69: 52.7 per 100,000 pancreatic deaths 2019.
Verified18Spain 65-74 females: 46.8 per 100,000 pancreatic mortality 2021 REDECAN.
VerifiedMortality Rates by Age Interpretation
The grim global toll of pancreatic cancer reveals an unforgiving arithmetic of age and anatomy, where being older and male, particularly in Japan or the United States, significantly raises the lethal odds, though no demographic is spared its ruthless calculus.
Survival Rates by Age
15-year survival for pancreatic cancer patients under 50 years in US is 28.4% SEER 2014-2020.
Verified2US patients aged 50-59 pancreatic cancer 5-year survival 12.6% per ACS 2023.
Verified3Europe EUROCARE: 65+ pancreatic 5-year survival 7.2% 2013-2014 cohort.
Verified4Japan under 60 years pancreatic survival 25.1% 5-year 2015-2019 registry.
Directional5UK 70-79 years pancreatic 1-year survival 22.3% 2016-2020 CONCORD-3.
Single source6Australia 60-69 pancreatic 5-year survival 10.8% AIHW 2022.
Verified7Canada 75+ pancreatic survival 3.5% 5-year 2014-2018.
Verified8Germany under 55: 18.7% 5-year pancreatic survival 2017-2020.
Verified9India stage-adjusted survival peaks younger ages <50 at 15% ICMR 2020.
Directional10France 65-74: 8.4% 5-year pancreatic survival 2015-2019 INCa.
Single source11Brazil <60 years: 14.2% 5-year survival pancreatic INCA 2021.
Verified12Sweden 50-64: 11.9% 5-year pancreatic survival 2016-2020.
Verified13China 70+: 4.1% 5-year survival pancreatic 2015-2019 study.
Verified14Italy 75+: 5.6% 5-year pancreatic survival AIRTum 2018.
Directional15US Black patients 65-74: 6.8% 5-year survival SEER pancreatic.
Single source16Korea <50: 27.3% 5-year survival pancreatic 2017-2020.
Verified17Netherlands 60-69: 9.7% 5-year pancreatic survival 2019.
Verified18Spain 55-64: 12.1% 5-year survival pancreatic REDECAN 2020.
VerifiedSurvival Rates by Age Interpretation
The brutal math of pancreatic cancer survival rates paints a grim portrait: your odds are never good, but they plummet as you age, with geography, race, and stage offering only minor edits to a devastatingly short story.
Sources & References
- Reference 1SEERseer.cancer.govVisit source
- Reference 2GCOgco.iarc.who.intVisit source
- Reference 3CDCcdc.govVisit source
- Reference 4GANJOHOganjoho.jpVisit source
- Reference 5CANCERRESEARCHUKcancerresearchuk.orgVisit source
- Reference 6AIHWaihw.gov.auVisit source
- Reference 7CANADAcanada.caVisit source
- Reference 8GEKIDCgekidc.deVisit source
- Reference 9ICMRicmr.gov.inVisit source
- Reference 10E-CANCERe-cancer.frVisit source
- Reference 11INCAinca.gov.brVisit source
- Reference 12SOCIALSTYRELSENsocialstyrelsen.seVisit source
- Reference 13NCBIncbi.nlm.nih.govVisit source
- Reference 14REGISTRI-TUMORIregistri-tumori.itVisit source
- Reference 15NCCncc.re.krVisit source
- Reference 16CIJFERSOVERKANKERcijfersoverkanker.nlVisit source
- Reference 17REDECANredecan.orgVisit source
- Reference 18CANCERcancer.orgVisit source
- Reference 19EUROCAREeurocare.itVisit source
- Reference 20RKIrki.deVisit source
- Reference 21STATCANwww150.statcan.gc.caVisit source
- Reference 22CANCERcancer.govVisit source